CLSD CLEARSIDE BIOMEDICAL INC Product Launches 8-K Filing 2023 - Results of OASIS Extension Study Clearside Biomedical, Inc. announced positive results from the extension study of their OASIS Phase 1/2a clinical trial of CLS-AX in wet AMD.Get access to all SEC 8-K filings of the CLEARSIDE BIOMEDICAL INC